Sepsis in pregnancy and the puerperium

Int J Obstet Anesth. 2018 Nov:36:96-107. doi: 10.1016/j.ijoa.2018.04.010. Epub 2018 Jun 18.

Abstract

Sepsis remains a leading cause of maternal morbidity and mortality. Recognition and treatment of maternal sepsis are often delayed due to the physiological adaptations of pregnancy and vague or absent signs and symptoms during its initial presentation. Over the past decade, our understanding of sepsis has evolved and maternal early warning systems have been developed in an effort to help providers promptly identify and stratify parturients who are at risk. In addition, new consensus definitions and care bundles have recently been published by the World Health Organization and the Surviving Sepsis Campaign to facilitate earlier recognition and timely management of sepsis. In this narrative review, we summarize the available evidence about sepsis and provide an overview of the research efforts focused on maternal sepsis to date. Controversies and challenges surrounding the anesthetic management of parturients with sepsis or at risk of developing sepsis during pregnancy or the puerperium will be highlighted.

Keywords: Maternal sepsis; Obstetric anesthesia; Pregnancy; Puerperium; Sepsis.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Cardiotonic Agents / therapeutic use
  • Female
  • Fluid Therapy / methods
  • Humans
  • Maternal Mortality
  • Postpartum Period
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis*
  • Pregnancy Complications, Infectious / prevention & control
  • Pregnancy Complications, Infectious / therapy*
  • Puerperal Disorders / diagnosis*
  • Puerperal Disorders / prevention & control
  • Puerperal Disorders / therapy*
  • Risk Factors
  • Sepsis / diagnosis*
  • Sepsis / prevention & control
  • Sepsis / therapy*
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Anti-Infective Agents
  • Cardiotonic Agents
  • Vasoconstrictor Agents